OTTAWA, Ontario--(BUSINESS WIRE)--Jan. 21, 2013--
Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and
services to the global health science market, today announced that the
Company will report its fourth quarter and fiscal 2012 financial results
before markets open on January 28, 2013.
Fourth Quarter and Fiscal 2012 Conference Call
will also host an analyst conference call with Steve West, Chief
Executive Officer and Peter Dans, Chief Financial Officer, to discuss
the results. The call will be webcast live on January 28, 2013 at 10:00
Interested parties may access the live webcast of the conference call
from the Nordion website at www.nordion.com.
To participate, please dial 1-866-223-7781 (toll-free North America) or
1-416-340-8018 (International). Following the call, an audio archive
will be available on the website at www.nordion.com.
About Nordion Inc.
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a
global health science company that provides market-leading products used
for the prevention, diagnosis and treatment of disease. We are a leading
provider of targeted therapies, sterilization technologies and medical
isotopes that benefit the lives of millions of people in more than 60
countries around the world. Our products are used daily by
pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. Nordion has
approximately 500 highly skilled employees worldwide. Find out more at www.nordion.com
and follow us at http://twitter.com/NordionInc.
Source: Nordion Inc.
Tanya Pobuda, (613) 592-3400
Raman, (613) 595-4580